PURPOSE: To characterize the population of HIV+ Brazilian patients with late introduction of antiretroviral therapy (ARVT), using information from the Laboratory Exam Control System. METHODS: The study analyzed 84,694 patients, representing all individuals in Brazil age 15 or over with an initial CD4+ T lymphocyte count requested between 2003 and 2006, and whose ARVT start date was later than their initial CD4+ T cell count. These patients were considered antiretroviral treatment naive. The initial CD4+ T cell distribution was analyzed according to sex, age, region and year. RESULTS: Most of the patients were between 15 and 49 years of age (91%); 56% were males; 76% were asymptomatic; 50% lived in the Southeastern region of the country, with an additional 20% in the South. Initial CD4+ counts for one-third of the patients were less than 200 cells/mm(3). When combined with the number of symptomatic individuals, 41% of the total group was in need of immediate ARVT. This group included 47% of the men and 53% of the patients aged 50 years and over. CONCLUSIONS: Despite universal access to ARVT in Brazil, results show that a high proportion of patients initiate ARVT at an advanced stage of disease, indicating the need to develop strategies to promote early diagnosis of HIV infection nationwide.
PURPOSE: To characterize the population of HIV+ Brazilian patients with late introduction of antiretroviral therapy (ARVT), using information from the Laboratory Exam Control System. METHODS: The study analyzed 84,694 patients, representing all individuals in Brazil age 15 or over with an initial CD4+ T lymphocyte count requested between 2003 and 2006, and whose ARVT start date was later than their initial CD4+ T cell count. These patients were considered antiretroviral treatment naive. The initial CD4+ T cell distribution was analyzed according to sex, age, region and year. RESULTS: Most of the patients were between 15 and 49 years of age (91%); 56% were males; 76% were asymptomatic; 50% lived in the Southeastern region of the country, with an additional 20% in the South. Initial CD4+ counts for one-third of the patients were less than 200 cells/mm(3). When combined with the number of symptomatic individuals, 41% of the total group was in need of immediate ARVT. This group included 47% of the men and 53% of the patients aged 50 years and over. CONCLUSIONS: Despite universal access to ARVT in Brazil, results show that a high proportion of patients initiate ARVT at an advanced stage of disease, indicating the need to develop strategies to promote early diagnosis of HIV infection nationwide.
Authors: Ronaldo I Moreira; Paula M Luz; Claudio J Struchiner; Mariza Morgado; Valdilea G Veloso; Jeanne C Keruly; Beatriz Grinsztejn; Richard D Moore Journal: J Acquir Immune Defic Syndr Date: 2011-08 Impact factor: 3.731
Authors: Jessica F Magidson; Katie B Biello; Steven A Safren; Joshua G Rosenberger; David S Novak; Kenneth H Mayer; Matthew J Mimiaga Journal: AIDS Care Date: 2015-03-04
Authors: Beatriz Grinsztejn; Valdilea G Veloso; Ruth K Friedman; Ronaldo I Moreira; Paula M Luz; Dayse P Campos; José H Pilotto; Sandra W Cardoso; Jeanne C Keruly; Richard D Moore Journal: AIDS Date: 2009-10-23 Impact factor: 4.177
Authors: Carina Cesar; Bryan E Shepherd; Alejandro J Krolewiecki; Valeria I Fink; Mauro Schechter; Suely H Tuboi; Marcelo Wolff; Jean W Pape; Paul Leger; Denis Padgett; Juan Sierra Madero; Eduardo Gotuzzo; Omar Sued; Catherine C McGowan; Daniel R Masys; Pedro E Cahn Journal: PLoS One Date: 2010-06-01 Impact factor: 3.240
Authors: Inês Dourado; Sarah MacCarthy; Carlos Lima; Maria Amélia Veras; Ligia Kerr; Ana Maria de Brito; Sofia Gruskin Journal: AIDS Care Date: 2014-07-17
Authors: Sheri A Lippman; André R S Périssé; Valdiléa G Veloso; Patrick S Sullivan; Susan Buchbinder; R Craig Sineath; Beatriz Grinsztejn Journal: Cad Saude Publica Date: 2014-04 Impact factor: 1.632
Authors: Alexandre Grangeiro; Maria Mercedes Escuder; Paulo Rossi Menezes; Rosa Alencar; Euclides Ayres de Castilho Journal: PLoS One Date: 2011-01-25 Impact factor: 3.240
Authors: Marta Driemeier; Sônia Maria Oliveira de Andrade; Elenir Rose Jardim Cury Pontes; Anamaria Mello Miranda Paniago; Rivaldo Venâncio da Cunha Journal: Clinics (Sao Paulo) Date: 2012 Impact factor: 2.365